Susan Hasty, Publisher
Table of Contents . . . May 26th, 1997Non-Subscriber - Summaries Only
Conference Coverage (AACR) - Salmonella typhimurium Scrutinized as Anticancer Vector
Conference Coverage (AACR) - Antisense Therapy Targets Cancer Angiogenesis
Conference Coverage (AACR) - Attenuated Salmonella typhimurium Targets Cancer Cells
Conference Coverage (AACR) - Phase I Trial of GD3-Lactone-KLH Melanoma Vaccine Presented
Conference Coverage (AACR) - Tri-Partner Protocol Enhances Vaccine Antitumor Immunity
Conference Coverage (AACR) - Tumor Amplified Protein Expression Therapy with Salmonella Vector
Conference Coverage (NCVDG) - Merck HIV DNA Vaccine Protects Monkeys; Human Trials Begin
Conference Coverage (NCVDG) - Vaccine Therapy Targets Antigens for CTL Attack
Alcoholism - Study Finds Alcoholism-Linked Genes
Biological Clock (Circadian Rhythm) - Scientists Study Body Clock Gene
Industry News - New Drug Delivery Technology Complements Gene Therapy
HIV Vaccines - "New Immunogen Representing HIV-1 Envelope Variability."
Immunology (HIV-1) - "A Novel Leusine Zipper Protein Expression Controlled by the HIV-1 Tat and p53."
Antisense Technology - "Analysis of Oligonucleotides by HPLC-Electrospray Ionization Mass Spectrometry."
HIV Gene Therapy - "Potent Inhibition of Human Immunodeficiency Virus Type 1 in Primary T Cells and Alveolar Macrophages by a Combination Anti-Rev Strategy Delivered in an Adeno-Associated Virus Vector."
Hepatitis Gene Therapy - "Characterization of CD8+ Cytotoxic T-Lymphocyte Responses after Genetic Immunization with Retrovirus Vectors Expressing Different Forms of the Hepatitis B Virus Core and e Antigens."